Course: PC1320 Introductory Pharmacology & PharmacotherapyInstitution: James Cook University (JCU)Celebrating: 50 Years (1970 - 2020)
Topic: Cardiovascular Pharmacology: ACE Inhibitors and A2R BlockersPresenter: Robiul Islam, PhDAcknowledgment to: Assoc Prof John Smithson, Pharmacy, College of Medicine and Dentistry
Understand the role of the Renin-angiotensin-aldosterone system (RAAS) in the physiological regulation of blood pressure and electrolytes.
Apply pharmacological principles of ACE inhibitors and A2 receptor blockers (A2RBs) for effective management of hypertension and related cardiovascular conditions.
Predict potential side effects and adverse reactions based on the pharmacological activities of ACE inhibitors and A2RBs.
Describe practical strategies for pharmacists to optimize the therapeutic benefits and minimize risks associated with ACE inhibitors and A2RBs in diverse patient populations.
The material presented is compliant with Copyright Regulations 1969, which underscores the significance of proper acknowledgment in any reproduction or communication under copyright laws.
ACE inhibitors and A2 receptor blockers (A2RBs) interact with the Renin-Angiotensin-Aldosterone System (RAAS), a crucial physiological pathway governing blood pressure and fluid balance.
Hypertension: Management of elevated blood pressure to reduce the risk of heart disease and stroke.
Chronic Heart Failure: Provides symptomatic relief and improves survival rates.
Diabetic Neuropathy: Reduces progression of renal complications due to diabetes through protective renal effects.
Prevention of Progressive Renal Failure: Particularly in patients with diabetes and proteinuria.
Generic Names:
Captopril
Enalapril
Fosinopril
Lisinopril
Perindopril
Quinapril
Ramapril
TrandolaprilCommon suffix: ‘pril’
Generic Names:
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
ValsartanCommonly referred to as ‘sartans’
A focus on Angiotensin Converting Enzyme (ACE) inhibitors elucidates their significance in pharmacotherapy for various cardiovascular conditions.
ACE inhibitors operate by blocking the Angiotensin Converting Enzyme (ACE), which in turn prevents the conversion of Angiotensin I (a weak vasoconstrictor) into Angiotensin II (a potent vasoconstrictor). This mechanism plays a vital role in the reduction of blood pressure.
Key Components of the Pathway:
Liver: Produces Angiotensinogen, the precursor to angiotensin.
Kidneys: Release renin in response to decreased renal perfusion, initiating the pathway.
Lungs: ACE converts Angiotensin I to Angiotensin II.
Adrenal Gland: Secretes aldosterone, which influences sodium (Na+) and water retention, significantly impacting blood pressure levels.
Decreased Vascular Tone: Results in lowered blood pressure.
Inhibition of Aldosterone Release: Leads to reduced sodium and water reabsorption, contributing to the lowering of blood volume and blood pressure.
Increased Renin Release: Occurs due to lack of feedback inhibition by angiotensin II.
Bradykinin Levels: Elevated levels can induce vasodilation but may also lead to side effects such as cough.
Hypotension: Particularly postural hypotension can occur upon standing.
Dizziness and Fatigue: Commonly reported by patients upon initiation of therapy.
Gastrointestinal Discomfort: Nausea and headaches can ensue as side effects.
Renal Impairment: Monitoring kidney function is essential.
Hyperkalemia: Due to decreased aldosterone levels, leading to renal retention of potassium.
Cough: Linked to the accumulation of bradykinin as a direct consequence of ACE inhibition.
Angioedema: Characterized by asymmetric swelling of lips, tongue, and airway; this condition is critical and necessitates immediate medical intervention.
Presentation: Patients may exhibit asymmetric swelling, which can potentially obstruct airflow leading to asphyxiation, thereby constituting a medical emergency.
Ongoing literature highlights recommendations for medical management related to angioedema, emphasizing the importance of understanding this potentially serious adverse effect.
Half-Life Considerations: Most ACE inhibitors allow for once-daily dosing due to relatively long half-lives, with the exception of Captopril, which may require more frequent administration.
Notable Drug Interactions Include:
Potassium-sparing Diuretics: Heightens the risk of hyperkalemia.
Loop Diuretics: Potentially leads to hypotension when used concurrently.
NSAIDs: May exacer